Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 795

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 795
---
 on;

    ●
    buying
    or selling puts, calls, other derivative securities of the Company or any derivative securities that provide the economic equivalent
    of ownership of any of our securities or an opportunity, direct or indirect, to profit from any change in the value of our securities
    or engaging in any other hedging transaction with respect to our securities;

    ●
    using
    our securities as collateral in a margin account; and

    ●
    pledging
    our securities as collateral for a loan (or modifying an existing pledge).

While
the Company has not adopted a formal policy governing transactions by the Company in its securities, the Company will not engage in transactions
in Company securities, or adopt any securities repurchase plans, while in possession of material non-public information relating to the
Company or its securities other than in compliance with applicable law, subject to the policies and procedures adopted by the Company.

On
or around August 14, 2024, the Company was first made aware that one of its directors, through a wholly owned subsidiary, had
previously entered into certain collateral pledge agreements that resulted in the disposition of a substantial amount of shares in
the Company pursuant to those agreements without the Company’s knowledge. In addition, the Company also became aware that
approximately 300,000 thousand shares (or 31% of our then outstanding common stock as of August 14, 2024) were subject to a
further third-party pledge arrangement with a then significant stockholder of the Company. Upon learning of these transactions, the
board of directors has appointed an independent committee of the board of directors (the “Special Committee”) and
delegated to the Special Committee the authority to review these matters and determine action(s), if any, to be taken by the Company
in response thereto. Additionally, the Company formed another committee of the board of directors (the “Trading Review
Committee”) and delegated to the Trading Review Committee the authority to investigate and review the trading patterns of
certain of the Company’s stockholders and determine action(s), if any, to be taken by the Company in response thereto. The
Company values its stockholders and wants to have all available data at its disposal to act in its fiduciary capacity.

Section
16(a) Beneficial Ownership Reporting Compliance

Section
16(a) of the Exchange Act requires that our directors and executive officers, and persons who own more than ten percent of a registered
class of our equity securities,